53
Participants
Start Date
April 30, 2003
Study Completion Date
December 31, 2004
Tacrolimus Ointment 0.03%
Twice daily, 14 days treatment.
Tacrolimus Ointment 0.03%
Once daily, 14 days treatment.
Halifax
Vancouver
Waterloo
Helsinki
Drogheda
Dublin
Riga
London
Lead Sponsor
Astellas Pharma Inc
INDUSTRY